ODT - Odonate Therapeutics: Insiders Buying This Oncology Concern
The enemy is anybody who's going to get you killed, no matter which side he is on." - Joseph Heller, Catch-22
I had a question from a Seeking Alpha follower last week on a company that has not been public for at least a year and a half yet. I usually leave IPOs alone until they have been 'seasoned'. However, I recently did a 'deep dive' on this name for Insiders Forum members. I have updated that thesis with the latest data and it is provided in the paragraphs below.
Company Overview:
Odonate Therapeutics,